Search
for
Sort by
Research 151–180 of 1000+
- COVID-19 in adult patients with pre-existing chronic cardiac, respiratory and metabolic disease: a critical literature review with clinical recommendations
- Treatment of Obstructive Sleep Apnea Improves Cardiometabolic Function in Young Obese Women with Polycystic Ovary Syndrome
- American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the Diagnosis and Treatment of Hyperandrogenic Disorders
- Effects of lifelong testosterone exposure on health and disease using Mendelian randomization
- Metabolic syndrome – a new definition and management guidelines A joint position paper by the Polish Society of Hypertension, Polish Society for the Treatment of Obesity, Polish Lipid Association, Polish Association for Study of Liver, Polish Society of Family Medicine, Polish Society of Lifestyle Medicine, Division of Prevention and Epidemiology Polish Cardiac Society, “Club 30” Polish Cardiac Society, and Division of Metabolic and Bariatric Surgery Society of Polish Surgeons
- Androgenetic alopecia as an early marker for hypertension
- The Association of Cutaneous Lichen Planus and Metabolic Syndrome: A Case-Control Study
- The Use of Anabolic Steroids by Bodybuilders in the State of Sergipe, Brazil
- Author response: Effects of lifelong testosterone exposure on health and disease using Mendelian randomization
- Early androgenetic alopecia as a possible indicator of diabetes mellitus and its link to cardiovascular risks: a cross-sectional study
- A Large Benign Adrenocortical Adenoma Cosecreting Testosterone and Cortisol
- The Role of rs6152 Allele and Non-Genetic Factors in Androgenetic Alopecia: A Pilot Study in the Indonesian Local Population
- Androgenetic alopecia: Traditional cardiovascular risk factors, metabolic syndrome, and component traits among Nigerian adults
- Frontal Fibrosing Alopecia – a review and a practical guide for clinicians
- Early-onset Male Androgenetic Alopecia and Metabolic Syndrome: Are They Associated?
- Risks for metabolic syndrome and cardiovascular diseases in both male and female patients with androgenetic alopecia
- COVID-19 and endocrine and metabolic diseases. An updated statement from the European Society of Endocrinology
- Androgenetic alopecia and risk of coronary artery disease
- Mechanistic and therapeutic insight into the effects of cinnamon in polycystic ovary syndrome: a systematic review
- Severe androgenetic alopecia as a maker of metabolic syndrome in male patients of androgenetic alopecia: a hospital based case control study
- Prevalence of Metabolic Syndrome and Cardiovascular Risk Factors in Early Onset Male Androgenetic Alopecia - A Cross Sectional Study in a Tertiary Care Hospital
- Floral attractants in the black orchid Brasiliorchis schunkeana (Orchidaceae, Maxillariinae): clues for presumed sapromyophily and potential antimicrobial activity
- Squarticles as the nanoantidotes to sequester the overdosed antidepressant for detoxification
- Oral Minoxidil in the Treatment of Hypertensive Crisis
- Lipid profile in androgenetic alopecia
- Low-Dose Oral Minoxidil During Chemotherapy: A Review of the Mechanism and Current Evidence
- Tissue engineering strategies combining molecular targets against inflammation and fibrosis, and umbilical cord blood stem cells to improve hampered muscle and skin regeneration following cleft repair
- Risk factors for diabetic foot ulcers mortality and novel negative pressure combined with platelet-rich plasma therapy in the treatment of diabetic foot ulcers
- Hypertensive crisis associated with St. John’s Wort
- Contraception and the dermatologist